China SXT Pharmaceuticals, Inc.
SXTC
$1.46
-$0.0396-2.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.30M | 1.25M | 5.80M | 1.35M | -3.10M |
| Total Depreciation and Amortization | 82.40K | 125.70K | 169.00K | 186.10K | 203.20K |
| Total Amortization of Deferred Charges | 520.80K | 344.60K | 168.40K | 230.60K | 292.80K |
| Total Other Non-Cash Items | 1.33M | -3.03M | -7.39M | -3.17M | 1.06M |
| Change in Net Operating Assets | -971.80K | -1.21M | -1.44M | -912.70K | -381.60K |
| Cash from Operations | -2.35M | -2.53M | -2.71M | -2.32M | -1.93M |
| Capital Expenditure | -2.00K | -4.50K | -7.00K | -7.00K | -7.00K |
| Sale of Property, Plant, and Equipment | 65.60K | 53.10K | 40.60K | 20.30K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 6.90K | 13.80K | 23.60K | 33.40K |
| Cash from Investing | 63.60K | 55.50K | 47.40K | 36.90K | 26.40K |
| Total Debt Issued | 7.69M | 8.22M | 8.76M | 5.13M | 1.50M |
| Total Debt Repaid | -1.92M | -710.50K | 497.00K | -1.76M | -4.01M |
| Issuance of Common Stock | 2.76M | 1.38M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -135.20K | -156.60K | -178.00K | -144.20K | -110.40K |
| Cash from Financing | 8.40M | 8.74M | 9.07M | 3.23M | -2.62M |
| Foreign Exchange rate Adjustments | -65.20K | 283.20K | 631.60K | -66.80K | -765.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.05M | 6.55M | 7.05M | 878.30K | -5.29M |